Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone furoate/vilanterol inhalation powder

fluticasone furoate/vilanterol · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Fluticasone furoate/vilanterol inhalation powder, covering 2013-07-30 to 2019-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma [Phase 3]

See pricing